Biotech Valuations Rise as New Clinical Platforms Show Progress
AUSTIN, Texas, Nov. 24, 2025 (GLOBE NEWSWIRE) — BioMedWire Editorial Coverage: As advanced biotech programs move closer to commercialization, fair-value adjustments under U.S. Generally Accepted Accounting Principles (GAAP) are increasingly recognized as mean
(Financial Post, 2025-11-24T13:32:02Z)